Sign Up to like & get
recommendations!
1
Published in 2020 at "Nature Reviews Microbiology"
DOI: 10.1038/s41579-020-0351-x
Abstract: A large screen for antimalarial drugs identified protease inhibitors that target three stages of the malaria parasite.
read more here.
Keywords:
microbiology;
triple hit;
hit plasmodium;
Sign Up to like & get
recommendations!
0
Published in 2020 at "American journal of clinical pathology"
DOI: 10.1093/ajcp/aqz208
Abstract: OBJECTIVES To better characterize the clinicopathologic presentation and outcomes of follicular lymphoma with MYC and BCL2 and/or BCL6 rearrangements (double-hit and triple-hit follicular lymphoma), we present three cases from our institution and perform a literature…
read more here.
Keywords:
lymphoma;
triple hit;
double hit;
follicular lymphoma ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of cellular and molecular medicine"
DOI: 10.1111/jcmm.16999
Abstract: Triple-hit lymphoma (THL), which is classified into high-grade B-cell lymphoma with rearrangements of MYC, BCL2 and BCL6, presents aggressive biological behaviour. High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (auto-HSCT) is considered to be…
read more here.
Keywords:
triple hit;
dose rituximab;
high dose;
hit lymphoma ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "International heart journal"
DOI: 10.1536/ihj.21-513
Abstract: Cardiac double-hit and triple-hit lymphomas (DHLs, THLs) are rare; in fact, studies examining both DHL and THL remain scarce. THL with cardiac involvement constitutes a rare disease with few cases reported so far. Thus, in…
read more here.
Keywords:
triple hit;
hit lymphoma;
cardiac triple;
primary cardiac ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.599493
Abstract: MYC/BCL2/BCL6 triple-hit lymphoma (THL) is an uncommon subset of high-grade B-cell lymphoma with aggressive clinical behavior and poor prognosis. TP53 mutation is an independently poor progonistic indicator in patients with THL, hence novel therapeutic strategies…
read more here.
Keywords:
triple hit;
car19 cells;
therapy;
car19 ... See more keywords